» Articles » PMID: 37628629

Review of Disease-Specific MicroRNAs by Strategically Bridging Genetics and Epigenetics in Oral Squamous Cell Carcinoma

Overview
Journal Genes (Basel)
Publisher MDPI
Date 2023 Aug 26
PMID 37628629
Authors
Affiliations
Soon will be listed here.
Abstract

Oral squamous cell carcinoma (OSCC) is one of the most prevalent human malignancies and a global health concern with a poor prognosis despite some therapeutic advances, highlighting the need for a better understanding of its molecular etiology. The genomic landscape of OSCC is well-established and recent research has focused on miRNAs, which regulate gene expression and may be useful non-invasive biomarkers or therapeutic targets. A plethora of findings regarding miRNA expression have been generated, posing challenges for the interpretation and identification of disease-specific molecules. Hence, we opted to identify the most important regulatory miRNAs by bridging genetics and epigenetics, focusing on the key genes implicated in OSCC development. Based on published reports, we have developed custom panels of fifteen major oncogenes and five major tumor suppressor genes. Following a miRNA/target gene interaction analysis and a comprehensive study of the literature, we selected the miRNA molecules which target the majority of these panels that have been reported to be downregulated or upregulated in OSCC, respectively. As a result, miR-34a-5p, miR-155-5p, miR-124-3p, miR-1-3p, and miR-16-5p appeared to be the most OSCC-specific. Their expression patterns, verified targets, and the signaling pathways affected by their dysregulation in OSCC are thoroughly discussed.

Citing Articles

Identification of Stage-Specific microRNAs that Govern the Early Stages of Sequential Oral Oncogenesis by Strategically Bridging Human Genetics with Epigenetics and Utilizing an Animal Model.

Gintoni I, Vassiliou S, Chrousos G, Yapijakis C Int J Mol Sci. 2024; 25(14).

PMID: 39062890 PMC: 11277563. DOI: 10.3390/ijms25147642.


Analyzing Pooled Microarray Gene Expression Data to Uncover Common Pathways in Periodontitis and Oral Squamous Cell Carcinoma from the Gene Expression Omnibus.

Karri R, Amrutha R, Shrinivas , Bojji M, Kumar K, Benarji K J Pharm Bioallied Sci. 2024; 16(Suppl 2):S1515-S1521.

PMID: 38882729 PMC: 11174343. DOI: 10.4103/jpbs.jpbs_1180_23.

References
1.
Bugshan A, Farooq I . Oral squamous cell carcinoma: metastasis, potentially associated malignant disorders, etiology and recent advancements in diagnosis. F1000Res. 2020; 9:229. PMC: 7194458. DOI: 10.12688/f1000research.22941.1. View

2.
Hu S, Wang H, Yan D, Lu W, Gao P, Lou W . Loss of miR-16 contributes to tumor progression by activation of tousled-like kinase 1 in oral squamous cell carcinoma. Cell Cycle. 2018; 17(18):2284-2295. PMC: 6226226. DOI: 10.1080/15384101.2018.1526601. View

3.
Rahmani A, Alzohairy M, Babiker A, Rizvi M, Elkarimahmad H . Clinicopathological significance of PTEN and bcl2 expressions in oral squamous cell carcinoma. Int J Clin Exp Pathol. 2012; 5(9):965-71. PMC: 3484492. View

4.
Gobin E, Bagwell K, Wagner J, Mysona D, Sandirasegarane S, Smith N . A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential. BMC Cancer. 2019; 19(1):581. PMC: 6567474. DOI: 10.1186/s12885-019-5768-0. View

5.
Pylayeva-Gupta Y, Grabocka E, Bar-Sagi D . RAS oncogenes: weaving a tumorigenic web. Nat Rev Cancer. 2011; 11(11):761-74. PMC: 3632399. DOI: 10.1038/nrc3106. View